On May 13, the Centers for Medicare & Medicaid Services (CMS) announced a nationwide enrollment moratorium on new Medicare hospice and home health agency (HHA) participants. The announcement follows the introduction of Rhode Island House Bill 8214 in February 2026, which, if enacted, would freeze new state licensure for home care, home nursing care, and hospice providers for at least five years. Though coincidentally close in time, the two actions are driven by fundamentally different policy rationales and carry very different consequences for providers, investors, and patients.

The Federal Action: Fraud Prevention as the Driving Force

The CMS moratorium, announced in coordination with Vice President JD Vance’s Anti-Fraud Task Force, imposes a six-month, nationwide pause on new Medicare enrollment for hospices and HHAs. The stated justification is fraud. CMS cited “systemic and deeply troubling fraud” in both sectors, characterizing hospice and home health billing as among the highest-risk categories in the Medicare program. The moratorium applies to initial enrollment applications and also to certain changes in majority ownership, a mechanism CMS identified as frequently used by bad actors to obscure control and evade detection.

The scale of the underlying problem is significant: in Los Angeles alone, CMS suspended payments to approximately 800 hospices and HHAs responsible for $1.4 billion in annual Medicare spending. The nationwide moratorium eliminates the option, historically available to fraudulent operators, of simply relocating across state lines to restart enrollment in a new jurisdiction.

Current enrollments are unaffected, and existing providers may continue delivering services without interruption. The moratorium does, however, create real complications for pending acquisitions, new market entrants, and de novo operations, particularly where transactions involve changes in majority ownership that may fall within the moratorium’s scope.

The Rhode Island Proposal: Capacity Planning as the Driving Force

Rhode Island House Bill 8214 takes a markedly different approach. The bill would impose a moratorium on the issuance of new home care provider, home nursing care provider, and hospice provider licenses from July 1, 2026, through July 1, 2031. The rationale is not fraud but health systems planning: during the moratorium, the Rhode Island Department of Health (RIDOH) would conduct a statewide utilization and capacity study assessing current service availability, underserved areas and subpopulations, and other factors pertinent to home-based healthcare utilization.

The bill’s structure is notably rigid. The number of licenses in effect as of June 30, 2026, would serve as the maximum in each category, subject to downward adjustment if active licenses decline by five percent or more in any calendar year. Should RIDOH fail to produce the required report by July 1, 2031, the moratorium would automatically remain in effect, potentially extending indefinitely. Limited exceptions exist for emergency circumstances, pending certificate of need applications, changes in ownership or effective control of existing licenses, and compelling circumstances affecting quality of life in specific areas or subpopulations.

Introduced on February 27, 2026, and referred to the House Health and Human Services Committee, the bill was recommended on April 9, 2026, to be held for further study, a status that leaves open the possibility of future action without immediate legislative momentum.

Key Contrasts and Practical Considerations

The following table highlights the key distinctions between the two actions:

Though the federal and state actions may appear to share a common purpose, they are, in effect, wildly different. The CMS moratorium is a six-month enforcement measure designed to root out fraud; it is temporary by design and leaves existing providers undisturbed. The Rhode Island proposal is something else entirely. At twelve times the duration of the federal pause, with a license ceiling that can only move downward, H.B. 8214 does not target bad actors; it erects a lasting, and potentially permanent, barrier to anyone seeking to enter the Rhode Island market in home care, home nursing care, or hospice. The risk of permanence is not speculative: R.I. Gen. Laws § 23-17-44 imposed a moratorium on new nursing facility licenses that remained in effect for over two decades, from August 21, 1996, to July 1, 2022. Providers, investors, and health systems should not conflate the two actions, and those with exposure to either should seek counsel promptly to assess their position relative to these distinct regulatory regimes.